ABSTRACT Due to its antimicrobial properties and low toxicity, human lysozyme (hLYZ) has broad application in the medical field and as a preservative used by the food industry. However, limited availability hinders its widespread use. Hence, we constructed a recombinant avian adeno-associated virus (rAAAV) that would specifically express hLYZ in the chicken oviduct and harvested hLYZ from the egg whites of laying hens. The oviduct-specific human lysozyme expression cassette flanked by avian adeno-associated virus (AAAV) inverted terminal repeats (ITRs) was subcloned into the modified baculovirus transfer vector pFBX, and then the recombinant baculovirus rBac-ITRLYZ was generated. The recombinant avian adenoassociated virus was produced by co-infecting Sf9 cells with rBac-ITRLYZ and the other 2 baculoviruses containing AAAV functional genes and structural genes, respectively. Electron microscopy and real-time PCR revealed that the recombinant viral particles were generated successfully with a typical AAAV morphology and a high titer. After one intravenous injection of each laying hen with 2 × 10 11 viral particles, oviductspecific expression of recombinant human lysozyme (rhLYZ) was detected by reverse transcription-PCR. The expression level of rhLYZ in the first wk increased to 258 ± 11.5 μg/mL, reached a maximum of 683 ± 16.4 μg/mL at the fifth wk, and then progressively declined during the succeeding 7 wk of the study. Western blotting indicated that the oviduct-expressed rhLYZ had the same molecular weight as the natural enzyme. These results indicate that an efficient and convenient oviduct bioreactor mediated by rAAAV has been established, and it is useful for production of other recombinant proteins.
INTRODUCTION
Lysozymes (LYZs), which are muramidases or Nacetylmuamide glycanhydrolases, widely exist in saliva, tears, blood serum, human and cow milk, and avian egg whites. Chicken egg lysozyme (cLYZ) is composed of 129 amino acid residues and has a molecular mass of 14.3 kDa, and human lysozyme (hLYZ) is composed of 130 amino acid residues and has a molecular mass of 14.7 kDa. The cLYZ protein shares 59% identity in acids with hLYZ protein, but the antimicrobial activity of hLYZ is approximately 3-fold greater than that of cLYZ (Li et al., 1995) . Human lysozyme has the function of being anti-bacterial, anti-viral, and anti-tumor (Khalil et al., 1989) , so hLYZ is widely used in livestock farming, the food industry, and medical field.
Natural hLYZ can be extracted from human milk, the placenta, or saliva, but the limited source restricts its widespread use. Studies on recombinant human lysozyme (rhLYZ) expressed in microorganisms (Oka et al., 1999) , plants (Yang et al., 2003) , and animals (Maga et al., 2006) have been reported. Compared with other expression systems, the chicken oviduct bioreactor has several advantages, including high expression level, low cost, and appropriate glycosylation (Lee et al., 2013) . In our previous studies, active rhLYZ with correct molecular mass was successfully expressed in chicken egg white by injection of egg-laying hens with oviduct-specific expression vectors pOV1LYZ and pOV2LYZ. Although the expression level was relatively high, the expression time lasted for only about 10 d, which could not be significantly prolonged by repeated injection (Zhu et al., 2006; Zu et al., 2007) .
Adeno-associated virus (AAV) is a small nonpathogenic parvovirus that requires co-infection of helper adenovirus or herpes virus for replication. Due to the advantages of nonpathogenicity, low immunogenicity, broad cell tropism, and long-lasting expression, recombinant adeno-associated virus (rAAV) is one of the most promising gene transfer vectors, which is 2447 widely used in gene therapy and gene engineering vaccine research (During, 1997) . In this study, the oviductspecific LYZ gene expression cassette was cloned into the avian adeno-associated virus (AAAV) transfer vector, and high titer recombinant viruses were generated using the baculovirus/insect cell expression system. After intravenous injection of laying hens with the recombinant viruses, long-lasting and oviduct-specific expression of rhLYZ was obtained, suggesting the usefulness of the expression system for production of recombinant proteins.
MATERIALS AND METHODS

Construction of Recombinant Baculovirus
The hLYZ open reading frame sequence was amplified by PCR from pcDNA-LYZ (Sun et al. 2004 ), using primers 5 -gtactcgagatgaaggtctttgaaaggtgtg-3 and 5 -gtactcgagttacactccacaaccttgaaca-3 . The 50-μL PCR reaction contained 10 ng of pcDNA-LYZ, 30 μM each primer, 200 μM deoxynucleoside triphosphate, and 2.5 U of Pfu DNA polymerase (Promega, Madison, WI) . After denaturation at 95
• C for 3 min, 30-cycle PCR was performed using the following program: denaturation at 95
• C for 30 s, annealing at 58
• C for 30 s, and elongation at 72
• C for 45 s (7 min for the last cycle). The plasmid vector pAITR-OV5K containing the oviductspecific KLK1 expression cassette and AAAV inverted terminal repeats (ITRs) (Wang et al. 2008 ) was digested with restriction enzyme XhoI to remove the human tissue kallikrein (KLK1) ORF, and ligated with the PCR product digested with the same enzyme. The resulted plasmid was named pAITR-OVLYZ. The baculovirus expression vector pFastBacDual was digested with NheI and BamHI, blunt ended, self-circularized to remove the baculovirus specific promoter, and the resulting vector was named pFBX. The oviduct-specific LYZ expression cassette flanked by ITRs was cut out from the vector pAITR-OVLYZ by EcoRI, and inserted into the same site of pFBX, and the resulting vector was called pFB-AITR-OVLYZ (Figure 1 ). The recombinant plasmid was confirmed by sequence analysis. The vector pFB-AITR-OVLYZ was used to produce recombinant baculoviruses rBac-ITRLYZ with the Bac-to-Bac baculovirus expression system, according to the manufactures' instruction (Invitrogen, Carlsbad, CA).
Cell Culture
Spodoptera frugiperda Sf9 cells (Invitrogen) were maintained at 27
• C in Sf-900 serum-free medium (Gibco BRL, Grand Island, NY). Chicken embryonic fibroblast DF1 cells (ATCC CRL-12203; American Type Culture Collection, Manassas, VA), chicken embryonic liver cells (CEL; ATCC CRL-2117), and oviduct epithelial cells were grown at 37
• C in Dulbecco's modified Eagle's medium (DMEM; Gibco) supplemented with 10% fetal calf serum (FCS; Gibco), 100 U/mL of penicillin, and 100 mg/mL of streptomycin.
Production and Purification of rAAAV-LYZ Virus Particles
To produce the recombinant virus in insect cells, Sf9 cells at a density of 2 × 10 6 cells/mL in suspension culture were infected with 5 multiplicity of infection each of rBac-ITRLYZ, rBac-VP, and rBac-Rep. The recombinant baculovirus rBac-VP and rBac-Rep express the Cap and Rep proteins of AAAV, respectively. After 3 d of infection, cell pellets were collected by centrifugation and lysed by repeated freezing and thawing from −80
• C to 37
• C 3 times. The resultant rAAAV vector, namely, rAAAV-LYZ, was purified by PEG precipitation method as described previously (Matsushita et al., 1998) . Briefly, the supernatant was collected by centrifugation at 12,000 rpm for 10 min, filtered with 0.22 μm filter, and then extracted in 1/10 volume of chloroform by vigorous shaking at room temperature for one h. The viral particles in the upper phase were precipitated with 10% (wt/vol) PEG8000, and the precipitation was resolved in PBS, aliquoted, and stored at −80
• C. The concentration of vector genomes or "titer" was determined by quantitative real-time PCR assay on an iCycler iQ RT-PCR thermocycler (Bio-Rad, Hercules, CA). Proteinase K-treated rAAAV-LYZ was serially diluted and amplified by PCR, using SYBR Green master mix (Applied Biosystems, Foster City, CA) with primers specific to the LYZ gene, which was the same as that used above. The cycling conditions were as follows:
95
• C for 3 min, followed by 40 cycles of 95 • C for 30 s, 59
• C for 30 s, and 72
• C for 30 s. Linearized pFB-AITR-OVLYZ was employed as a copy number standard to make a standard curve.
Identification of rAAAV-LYZ Virus Particles
To identify rAAAV-LYZ morphologically, the purified viral particles were identified by electron microscopy (EM). Briefly, the samples were mounted on a carbon-coated paper grid at room temperature for 10 min, and carefully drained with a filter paper. After being negatively strained with 2% phosphotumgstic acid (pH7.4) for one min, the samples were observed under a transmission electron microscope (TEM; Tecnai 12, FEI, Hillsboro, Oregon). To identify rAAAV-LYZ immunologically, the purified viral particles were lysed in 1× sodium dodecyl sulfate (SDS) sample buffer, separated by 10% SDS-PAGE, and transferred to polyvinylidene difluoride membrane (F. Hoffmann-La Roche Ltd., Grenzacherstrasse, Switzerland). The membranes were blocked with 10% skimmed milk in PBS overnight, and incubated for 2 h at room temperature with mouse anti-VP3 antibody (1:100), which was prepared by immunizing mice with E. coli-expressed AAAV Cap protein as described previously (Li et al., 2013) . After washing 3 times in PBST, the bound antibodies were detected with horseradish peroxidase-labeled goat antimouse IgG (1:5000; Jackson ImmunoResearch, West Grove, PA). The protein bands were visualized by 3,3 -diaminobenzidine (DAB) tetrahydrochloride staining.
Immunofluorescence Assays (IFA)
DF1 cells, CEL cells, and oviduct epithelial cells were seeded on 24-well plates at a density of 2 × 10 5 cells/well and infected with rAAAV-LYZ. Three d after infection, cells were fixed for 20 min at room temperature with 4% paraformaldehyde and blocked for 60 min with 5% BSA in PBS. Conventional indirect immunofluorescence was performed using anti-hLYZ monoclonal antibody specific to hLYZ (1:200; Abcam, Cambridge, MA) as the first antibody, and FITC-labeled goat anti-mouse IgG (1:500; Jackson ImmunoResearch, USA) as the secondary antibody.
Viral Injection and Quantitative Measurement
Each of 5 egg-laying hens at 17 mo of age was injected via wing vein route with 2 × 10 11 viral genomes of rAAAV-LYZ. After injection, 4 to 5 eggs from each hen were collected weekly, and the egg whites were used for quantitative measurement of rhLYZ according to Lysozyme Human Elisa kit (Abcam, USA). The hLYZ standards or test samples were added on the 96 wells, which were pre-coated with the hLYZ specific antibody. After incubation for 2 h, the plates were incubated for one h at 25
• C with the hLYZ specific biotinylated detection antibodies. After washing 3 times in PBST, the plates were incubated for 30 min with streptavidinperoxidase conjugates, and unbound conjugates were washed away with PBST. The plates were incubated for 15 min with chromogen substrates, followed by the addition of stop solution. Absorbance was determined at 450 nm using a Bio-Rad microtiter plate reader. The hLYZ standards were used as positive controls to generate a standard curve, and the normal egg whites were used as empty controls. The expression level of hLYZ in test samples was calculated according to the standard curve. The final values were expressed as means ± SEM of 4 to 5 eggs from each hen.
Reverse Transcription (RT)-PCR
Twelve wk after rAAAV-LYZ injection, experimental hens were killed, and their hearts, livers, spleens, lungs, kidneys, skeletal muscles, and oviducts were collected for RNA extraction. The extracted RNA was digested for 30 min at 37
• C with DNaseI to remove possible contamination of viral DNA, and then used for reverse transcription according to the instruction for the RT-PCR kit (SangGong, Shanghai, China). The 20 μL RT reaction system contained 0.5 pmol of RNA inhibitor, one μL of reverse transcriptase, 10 pmol of dNTP, 2 μg of total RNA, and 10 pmol of each primer specific to hLYZ gene. After incubation at 42
• C for 90 min, a 35-cycle PCR reaction was performed using the following program: denaturation at 95
• C for 30 s, annealing at 53
• C for 30 seconds. The PCR product was observed by 1.0% agarose gel electrophoresis.
Western Blotting
Fifteen microliters of egg whites from normal and rAAAV-LYZ-injected hens at wk 8 after viral injection were lysed in 2× sodium dodecyl sulfate (SDS) sample buffer, separated by SDS-PAGE, and transferred to polyvinylidene difluoride membrane (F. HoffmannLa Roche Ltd., Grenzacherstrasse, Switzerland). The membranes were blocked with 10% skimmed milk in PBS overnight and incubated with anti-hLYZ monoclonal antibody (1:2000; Abcam, USA) for 2 h at room temperature. The bound antibodies were detected with anti-rabbit horseradish peroxidase conjugated IgG (1:5000; Jackson ImmunoResearch, USA). The protein bands were visualized by DAB tetrahydrochloride staining. The human lysozyme standard (Sigma, St. Louis, MO) was used as a positive control.
Antibacterial Activity Analysis in vitro
We used the cup-plate method to determine the antibacterial activity of rhLYZ in the egg whites of rAAAV-LYZ-injected hens. One hundred microliters of Micrococcus lysodeikticus (China General Microbiological Culture Collection Center, Beijing) cultivated to mid-log phase (OD600 ≈ 0.9) in LuriaBertani (LB) culture medium was mixed with 5 mL LB culture and plated on 100 mm LB agar dishes. Diluted samples (dilution, 1:100, 50 μL) from normal and rAAAV-LYZ-injected hens were added to the cup, and incubated at 37
• C for 24 hours. The size of inhibition zone was measured using vernier caliper. The human lysozyme standard was used as a positive control. The experiment was repeated 3 times.
RESULTS
Generation and Identification of rAAAV-LYZ
To generate the recombinant virus rAAAV-LYZ using the baculovirus/insect cell expression system, the oviduct-specific hLYZ expression cassette flanked by AAAV ITRs was subcloned into baculovirus transfer vector pFastBacDual. After co-infection with rBac-ITRLYZ, rBac-VP, and rBac-Rep, the recombinant viral particles were harvested and purified. The typical shape of parvovirus particles with a diameter of approximately 22 nm was shown by electron microscopy (Figure 2) . Western blotting analysis indicated that the composition and molecular weight of the recombinant viral structural proteins were in agreement with the expected (Figure 3) . Quantitative real-time PCR assay showed that the purified rAAAV-LYZ had a titer of 5.6 × 10 12 v.g./mL.
Expression of hLYZ in vitro
To investigate whether the recombinant viral vector could mediate the expression in avian cells, DF1 cells, CEL cells, and oviduct epithelial cells were in- fected with rAAAV-LYZ. Immunofluorescence assays showed that the recombinant proteins could be recognized by the anti-hLYZ antibodies in oviduct epithelial cells, while no reaction of hLYZ was observed in other cells (Figure 4) . These results indicated that rAAAV-LYZ was able to mediate the expression of the LYZ gene in chicken oviduct epithelial cells.
Dynamic Expression of hLYZ in Egg White
To detect the expression level of rhLYZ in egg white, after intravenous injection with viral particles, 4 to 5 eggs were collected weekly from each hen, and the expression levels were detected according to Lysozyme Human Elisa kit, using normal egg whites as control. As Figure 5 shows that the average expression level of rhLYZ in the first wk of injection increased to 258 ± 11.5 μg/mL, reached a maximum of 683 ± 16.4 μg/mL at the fifth wk, and then progressively decreased to 326 ± 13.2 μg/mL at the 12th wk (the end of the experiment). The expression levels of rhLYZ between the rAAAV-LYZ-injected group and the control group and between different wk were significantly different (P > 0.05).
Transcription of hLYZ cDNA in Oviduct Cells
To demonstrate the transcription of the hLYZ gene in oviduct epithelial cells, the different tissues of the experimental hens were collected at wk 12 after viral injection, and the total RNA was extracted for RT-PCR 11 viral genomes, total RNA was extracted from the oviducts (1), hearts (2), lungs (3), livers (4), spleens (5), kidneys (6), and muscles (7) of the rAAAV-LYZ-injected hens and the oviduct of a normal hen (8) for reverse transcription-PCR using hLYZ cDNAspecific primers.
analysis. The specific bands of the expected size were observed in the oviduct, but not in the heart, lung, liver, spleen, kidney, or skeletal muscle of viral injected hens (Figure 6 ). Western blotting analysis of recombinant human lysozyme expressed in the egg white of rAAAV-LYZ-injected hens. At wk 5 after viral injection, the pooled egg whites of 5 hens (2), the normal egg white (3), and the hLYZ standard (1) were separated on 12% SDS-PAGE and probed with rabbit anti-hLYZ monoclonal antibody as the first antibody and anti-rabbit IgG conjugated with horseradish peroxidase as the second antibody.
Western Blotting of rhLYZ
Egg whites of viral injected and normal hens were separated on 12% SDS-PAGE and transferred to polyvinylidene dithioride membrane for Western blotting analysis. As Figure 7 shows, a specific protein band of about 14.7 kDa was observed in the egg white of the rAAAV-LYZ-injected hen, but not in the egg white of the normal hen.
Antibacterial Activity of rhLYZ
To investigate the antibacterial activity of hLYZ expressed in the egg whites of the rAAAV-LYZ-injected hens, we used agar disc diffusion to analyze the lytic activity. From the results, we could see that the diameter of the inhibition zone of the egg whites injected with rAAAV-LYZ was significantly larger than that of the egg whites before injection (Figure 8 ).
DISCUSSION
Human lysozyme has broad prospects in clinical application, the food industry, and biological engineering development. The rhLYZ has been expressed in fungus and insect cells, but the expression levels are generally low (Spencer et al., 1999; Iwata et al., 2004) . In our prior work, rhLYZ was successfully expressed in egg whites by injection of laying hens with oviduct-specific expression vectors pOV1LYZ and pOV2LYZ. Although the expression level is relatively high, the expression lasts for only about 10 d, and repeated injection cannot significantly extend the expression time (Zhu et al., 2006; Zu et al., 2007) . So we need a more effective gene transfer vector.
The AAV is a promising gene transfer vector in gene therapy and vaccine research. In our previous experiments, rAAAV successfully mediated the long-lasting expression of the GFP reporter gene and other genes in viral-vector transduced avian cells (Wang et al., 2007; Wang et al., 2008; Wang et al., 2009) . So far, the AAAV vector is produced in HEK293 cells using the 3-plasmid method (Bossis and Chiorini, 2003; Estevez and Villegas, 2004 ). However, both rAAAV titer and scalability of the transient transfection method are limited. It was first reported that rAAV could be produced in insect cells without the helper viruses or genes (Urabe et al., 2002) . In order to overcome the disadvantages of the 3-plasmid method, we tried to produce rAAAV in Sf9 cells by co-infection with 3 kinds of recombinant baculovirus -rBac-OVLYZ, rBac-Rep, and rBac-VP. The viral titer of rAAAV produced in insect cells is nearly 30 times that of rAAAV produced in HEK293 cells (data not shown). The results of electron microscopy and Western blot analysis showed that rAAAV produced in Sf9 cells had the typical features of AAAV.
To avoid the possible effect of insect specific promoter on the expression of the exogenous gene controlled by oviduct-specific promoter, the insect specific promoter was cut off from the baculovirus transfer vector, and the hLYZ oviduct-specific expression cassette flanked by AAAV ITRs was inserted. RT-PCR analysis of the oviduct, heart, lung, spleen, kidney, liver, and skeletal muscle of rAAAV-LYZ-injected hens revealed that the hLYZ transcript was detected only in the oviduct, showing that the oviduct-specific promoter was sufficient to control the oviduct-specific expression of foreign genes in the recombinant viral vector.
Transgenic chickens are ideal bioreactors for production of foreign proteins, especially for pharmaceutical proteins. The transgenic bird lines with oviduct-specific expression cassette can be established, and thus the target proteins can be produced stably in egg whites of transgenic hens (Harvey et al., 2002; Lee et al., 2007) . To overcome the complex preparation process of transgenic chicken, we have made a lot of attempts in the transient oviduct bioreactor . In our system, laying hens were injected with 2 × 10 11 viral genomes of rAAAV-LYZ. The expression of rhLYZ in the egg whites reached the highest level of 683 ± 16.4 μg/mL at the fifth wk; the average expression level was about 500 ± 18.6 μg/mL, and the expression could last for at least 12 weeks. In comparison to 57.6 ± 1.40 μg/mL of stably transgenic chicken (Cao et al., 2015) , the expression level of rhLYZ in the transient oviduct bioreactor (about 500 μg/mL) was much higher. In addition, although the expression level mediated by rAAAV was slightly lower than that mediated by recombinant plasmid (about 700 μg/mL), the expression time was much longer than that mediated by recombinant plasmid (about 10 d). All these data indicate that our expression system is more effective and convenient.
In summary, an efficient and convenient oviductspecific expression platform mediated by rAAAV has been generated. The high level and long-lasting expression of rhLYZ in egg white indicate the usefulness of the method for expression of other recombinant proteins.
